Lou Portero

Urban Health Today

Recently, the U.S. Food and Drug Administration (FDA) reached an agreement with Abbott regarding reopening its Sturgis, Michigan, factory, following an earlier shutdown that led to the shortage of infant formula.&nbsp;Following FDA approval, Abbott may be set to reopen within two weeks. The reopening is hinged on a consent decree between FDA and Abbott plant in Michigan on the steps necessary to resume production and maintain the facility.In a press statement, the company stated that production would begin with EleCare&reg;, Alimentum&reg;, and metabolic formulas first, followed by Similac&reg; and other formulas. However, it may take six to eight weeks after reopening before these products are available on shelves.&nbsp;&ldquo;Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward reopening our Sturgis facility so we can ease the nationwide formula shortage. We look forward to working with the FDA to quickly and safely reopen the facility,&rdquo; said the chairman and CEO of Abbott, Robert B. Ford. &ldquo;We know millions of parents and caregivers depend on us, and we&rsquo;re deeply sorry that our voluntary recall worsened the nationwide formula shortage. We will work hard to re-earn the trust that moms, dads, and caregivers have placed in our formulas for more than 50 years.&rdquo;The company also stated that they were actively working to implement improvements and take corrective action in the press release.Source: <a href="https://abbott.mediaroom.com/2022-05-16-Abbott-Enters-into-Consent-Decree-with-U-S-Food-and-Drug-Administration-for-its-Sturgis,-Mich-,-Plant-Agreement-Creates-Pathway-to-Reopen-Facility">Abbott Press Release</a>

Payton White, BS

Unraveling the Genetic Factors in Alzheimer's Disease Risk in the African American Community

Alzheimer's & Dementia

CDC Guidelines Not Followed for Chlamydia and Gonorrhea, Study Finds

Female Urology

Tamara Thomas

Dr. Andrew Hertler Discusses Patient Selection for Popular Immunotherapy Drugs in Cancer Treatment

Esophageal Cancer

Latest News

Baby Formula Shortage: Abbott Set To Reopen Following Earlier Shut Down

Women's Health

The reopening is hinged on a consent decree between FDA and the Abbott plant in Michigan on the steps necessary to resume production and maintain the facility.

Baby Formula Shortage: Abbott Set To Reopen Following Shutdown

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe